Resazurin microtiter assay for isoniazid, rifampicin, ethambutol and streptomycin resistance detection in Mycobacterium tuberculosis: Updated meta-analysis

International Journal of Mycobacteriology
Ahmet Yilmaz CobanAnandi Martin

Abstract

The present meta-analysis aims to assess the evidence regarding the diagnostic accuracy and performance characteristics of the colorimetric redox indicator (CRI) assay with a special emphasis on the use of the resazurin microtiter assay (REMA) for determination of primary anti-tuberculosis drug resistance. By updating previous literature searches in Medline PubMed, ISI Web, Web of Science and Google academic databases of the REMA test for determination of primary anti-tuberculosis drug resistance, this meta-analysis includes 14 studies for isoniazid (INH); 15 studies for rifampicin (RIF); 6 studies for streptomycin (STR); and 5 studies for ethambutol (EMB). SROC curve analysis was performed for meta-analysis and diagnostic accuracy was summarized. Pooled sensitivity was 96% (94-98%) for INH, 97% (95-98%) for RIF, 92% (87-96%) for EMB and 92% (88-95%) for STR. Pooled specificity for INH, RIF, EMB and STR was 96% (95-98%), 99% (98-99%), 86% (81-89%) and 90% (87-93%), respectively. Susceptibility testing results had been obtained in 8-9days. In conclusion, REMA seems to be a reliable test for the determination of multi-drug resistant (MDR) isolates in laboratories with limited resources. However, few studies for STR and EMB have b...Continue Reading

References

Jul 18, 2002·Antimicrobial Agents and Chemotherapy·Juan-Carlos PalominoFrançoise Portaels
Oct 2, 2003·The Journal of Antimicrobial Chemotherapy·Elena BanfiCarlo Monti-Bragadin
Jun 11, 2004·The Journal of Antimicrobial Chemotherapy·Dihadenys LemusJuan Carlos Palomino
Jul 14, 2006·BMC Medical Research Methodology·Javier ZamoraArri Coomarasamy
Nov 19, 2008·Antimicrobial Agents and Chemotherapy·Agustina I de la IglesiaHéctor R Morbidoni
May 22, 2009·BMC Infectious Diseases·Freddie BwangaMoses L Joloba
Feb 25, 2011·Journal of Clinical Microbiology·Liliana RondónHoward E Takiff
Aug 13, 2011·Clinical and Vaccine Immunology : CVI·L L FloresS Laal

❮ Previous
Next ❯

Citations

Mar 22, 2016·RSC Advances·Aline A IshikawaCarlos D Garcia
Feb 15, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rita CsepregiMiklós Poór
Sep 14, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Majid Faridgohar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Biomédica : revista del Instituto Nacional de Salud
Lorena GonzálezMartha Isabel Murcia
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
Anandi MartinJuan Carlos Palomino
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
Ahmet Yilmaz CobanBelma Durupinar
© 2022 Meta ULC. All rights reserved